 Moderna on Tuesday said its vaccine that targets respiratory syncytial virus is effective at preventing disease in older adults. The vaccine was 83.7 effective at preventing lower respiratory tract disease, defined as two or more symptoms, in people ages 60 and older, according to the Boston biotech company. It was 82.4 effective at preventing lower ... Moderna says RSV vaccine is 84 effective at preventing disease... 